Tag Archives: First

Aegiq launches the world’s first compact true single-photon generator to enable high-performance applications in datacentre and lab environments

Aegiq’s first of its kind field-deployable prototype solution, iSPS, will launch today at the UK National Quantum Technologies Showcase in London, UK. London, UK; 11th November 2022: Aegiq, a start-up developing solutions to enable wide-scale adoption of quantum technologies, has today launched the world’s first compact true single-photon generator, iSPS. This is the first in… Read More »

EV Leisure Hotel Fund 1 acquires first properties for new European luxury hotel fund from 12.18. Group

12.18. Group and Engel & Völkers Asset Management launch the first fund specialised in tourism real estate for institutional investors The founding portfolio consists of three properties of 12.18. in Ibiza, Sardinia and in Scotland Further joint hospitality purchases for the fund in strategic cooperation with 12.18. are planned The independent license partner Engel &… Read More »

Britain’s daily Covid cases are DOWN for the first time in two months

Britain’s daily Covid cases are DOWN for first time in two months with 39,906 infections – but map reveals outbreak grew in all but FIVE of areas of England last week and more have been pinged than ever Today’s case numbers mark a 17.8% drop on the number last Thursday and first time they’ve fallen… Read More »

White House will prioritize Latin America and Caribbean with first tranche of 25M donated COVID-19 vaccines

The Biden administration unveiled plans to prioritize Latin America and Caribbean countries in the first phase of its plan to donate millions of coronavirus vaccines to poorer countries struggling under pandemic surges. “Today, the Administration announced its framework for sharing at least 80 million U.S. vaccine doses globally by the end of June and the… Read More »

Johnson & Johnson snares FDA nod for first exon 20-targeted drug in EGFR lung cancer

Just a few short months after Johnson & Johnson’s Janssen unit sent its targeted non-small cell lung cancer drug amivantamab to the FDA, the regulator has come back with a green light—a very specific one. Now christened Rybrevant, the drug is the first-ever treatment for non-small cell lung cancer with a group of epidermal growth factor receptor (EGFR) mutations found in… Read More »